Lorenz M. Mayr

4.6k total citations · 1 hit paper
51 papers, 3.1k citations indexed

About

Lorenz M. Mayr is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Computational Theory and Mathematics. According to data from OpenAlex, Lorenz M. Mayr has authored 51 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Computational Theory and Mathematics. Recurrent topics in Lorenz M. Mayr's work include Viral Infectious Diseases and Gene Expression in Insects (10 papers), RNA and protein synthesis mechanisms (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Lorenz M. Mayr is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (10 papers), RNA and protein synthesis mechanisms (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Lorenz M. Mayr collaborates with scholars based in Switzerland, Germany and Sweden. Lorenz M. Mayr's co-authors include Dejan Bojanic, Franz X. Schmid, Peter G. Fuerst, E. Ralf Schönbrunner, Michael Burgess, Ton N. Schumacher, Michael A. Milhollen, Peter S. Kim, Daniel L. Minor and Dieter Willbold and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Lorenz M. Mayr

51 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel trends in high-throughput screening

2009 467 citations Lorenz M. Mayr, Dejan Bojanic Current Opinion in Pharmacology profile →

Peers

Countries citing papers authored by Lorenz M. Mayr

Since Specialization

Citations

This map shows the geographic impact of Lorenz M. Mayr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenz M. Mayr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenz M. Mayr more than expected).

Fields of papers citing papers by Lorenz M. Mayr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenz M. Mayr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenz M. Mayr. The network helps show where Lorenz M. Mayr may publish in the future.

Co-authorship network of co-authors of Lorenz M. Mayr

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenz M. Mayr. A scholar is included among the top collaborators of Lorenz M. Mayr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenz M. Mayr. Lorenz M. Mayr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Secretome screening reveals immunomodulating functions of IFNα-7, PAP and GDF-7 on regulatory T-cells 2021 ·Scientific Reports ·Mei Ding, Rajneesh Malhotra, (unknown), Magnus Lundqvist, (unknown), (unknown), Ulf Gehrmann, (unknown), Douglas Ross‐Thriepland, (unknown), Björn Magnusson, Kris F. Sachsenmeier, Hanna Tegel, Sophia Hober, Mathias Uhlén, Lorenz M. Mayr, (unknown), Johan Rockberg, Lovisa Holmberg Schiavone	8
2	In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model 2019 ·BMC Biology ·Alba Carreras, Luna Simona Pane, Roberto Nitsch, Katja Madeyski-Bengtson, Michelle J. Porritt, Pınar Akçakaya, Amir Taheri‐Ghahfarokhi, Elke Ericson, Mikael Bjursell, Marta Pérez-Alcázar, Frank Seeliger, Magnus Althage, Ralph Knöll, Ryan Hicks, Lorenz M. Mayr, Rosie Perkins, Daniel Lindén, Jan Borén, Mohammad Bohlooly‐Y, Marcello Maresca	64
3	Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype 2018 ·EBioMedicine ·Mikael Bjursell, Michelle J. Porritt, Elke Ericson, Amir Taheri‐Ghahfarokhi, Maryam Clausen, Lisa U. Magnusson, Therése Admyre, Roberto Nitsch, Lorenz M. Mayr, (unknown), Frank Seeliger, Marcello Maresca, Mohammad Bohlooly‐Y, John Wiseman	57
4	Advances in recombinant protein expression for use in pharmaceutical research 2013 ·Current Opinion in Structural Biology ·R. Assenberg, Paul Wan, Sabine Geisse, Lorenz M. Mayr	132
5	Attempts to Express the A1-GMCSF Immunotoxin in the Baculovirus Expression Vector System 2012 ·Bioscience Biotechnology and Biochemistry ·Ali Jahanian‐Najafabadi, Saeid Bouzari, Mana Oloomi, Mehryar Habibi Roudkenar, Lorenz M. Mayr	7
6	Fragment-Based Screening by Biochemical Assays: Systematic Feasibility Studies with Trypsin and MMP12 2010 ·SLAS DISCOVERY ·Andreas Boettcher, Simon Ruedisser, P. Erbel, (unknown), Nikolaus Schiering, Ulrich Hassiepen, Pascal Rigollier, Lorenz M. Mayr, Julian Woelcke	29
7	A Fluorescence Lifetime-Based Assay for Abelson Kinase 2010 ·SLAS DISCOVERY ·(unknown), (unknown), (unknown), Peter Drueckes, Julian Woelcke, Lorenz M. Mayr, Ulrich Hassiepen	11
8	Knowledge-Based Virtual Screening: Application to the MDM4/p53 Protein–Protein Interaction 2009 ·Methods in molecular biology ·Edgar Jacoby, Andreas Boettcher, Lorenz M. Mayr, Nathan Brown, Jeremy L. Jenkins, Joerg Kallen, (unknown), Ulrich Schopfer, Pascal Furet, Keiichi Masuya, Joanna Lisztwan	17
9	Novel trends in high-throughput screening breakdown → 2009 ·Current Opinion in Pharmacology ·Lorenz M. Mayr, Dejan Bojanic	467
10	Development of a novel Gateway-based vector system for efficient, multiparallel protein expression in Escherichia coli 2008 ·Protein Expression and Purification ·Felix Freuler, (unknown), Marco Meyerhofer, Lukas Leder, Lorenz M. Mayr	21
11	Tackling the Chemogenomic Space by Novel Screening Technologies 2007 ·PubMed ·Lorenz M. Mayr	6
12	Single fluorescent protein-based Ca2+sensors with increased dynamic range 2007 ·BMC Biotechnology ·Ekaterina A. Souslova, Vsevolod V. Belousov, John G. Lock, Staffan Strömblad, Sergey Kasparov, А. P. Bolshakov, Pinelis Vg, Yulii A. Labas, Sergey Lukyanov, Lorenz M. Mayr, Dmitriy M. Chudakov	87
13	Application of mass spectrometry technologies for the discovery of low-molecular weight modulators of enzymes and protein–protein interactions 2007 ·Current Opinion in Chemical Biology ·(unknown), Lorenz M. Mayr	23
14	Readout Technologies for Highly Miniaturized Kinase Assays Applicable to High-Throughput Screening in a 1536-Well Format 2006 ·SLAS DISCOVERY ·Martin Klumpp, Andreas Boettcher, (unknown), (unknown), Jutta Blank, Lukas Leder, Michael Forstner, Johannes Ottl, Lorenz M. Mayr	28
15	Evaluation of two novel tag-based labelling technologies for site-specific modification of proteins 2006 ·International Journal of Biological Macromolecules ·(unknown), Felix Freuler, (unknown), Lorenz M. Mayr, Lukas Leder	59
16	A Baculovirus Expression Vector System for Simultaneous Protein Expression in Insect and Mammalian Cells 2005 ·Biotechnology Progress ·(unknown), Michael Forstner, Lorenz M. Mayr	14
17	Time reduction and process optimization of the baculovirus expression system for more efficient recombinant protein production in insect cells 2005 ·Protein Expression and Purification ·(unknown), (unknown), (unknown), Lorenz M. Mayr, Michael Forstner	29
18	Synthesis and characterization of fluorescent ubiquitin derivatives as highly sensitive substrates for the deubiquitinating enzymes UCH-L3 and USP-2 2005 ·Analytical Biochemistry ·(unknown), Alain Schilb, Virginie Riou, Lukas Leder, Bernd Gerhartz, Johann Zimmermann, Susanne Worpenberg, Ulf Eidhoff, Felix Freuler, (unknown), Lorenz M. Mayr, Johannes Ottl, (unknown), Ireos Filipuzzi	51
19	Solution Structure of Human GABAA Receptor-associated Protein GABARAP 2002 ·Journal of Biological Chemistry ·Thomas Stangler, Lorenz M. Mayr, Dieter Willbold	68
20	Stability and Folding Kinetics of Ribonuclease T1 are Strongly Altered by the Replacement of Cis-proline 39 with Alanine 1993 ·Journal of Molecular Biology ·Lorenz M. Mayr, Olfert Landt, Ulrich Hahn, Franz X. Schmid	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact